Law Commons^™

A More Harmonious Approach To Evaluate Pharmaceutical Patent Litigation’S “Reverse Payment Settlements”: What About The Patents?, Wenhao Leu

Wenhao Leu

"Reverse Payment Settlements" in pharmaceutical patent litigations represent one of the most challenging legal issues to resolve today because the courts do not have the right tools to do so. Though sharp divisions exist among the circuit courts with application of different tests, none of them has yet to achieve the right balance between the patentees' right to exclude and consumers' need for cheaper generic drugs.

This paper examines more closely the IP aspects of Reverse Payment Settlement agreements—the pharmaceutical patents—in order to resolve their antitrust issues. With weaker patents that are susceptible to invalidation or findings of non-infringement, pharmaceutical …

Striking An Efficient Balance: Making Sense Of Antitrust Standing In Class Action Certification Motions, Kelly J. Bozanic

Kelly J. Bozanic

Class actions are powerful litigation devices, especially in antitrust cases. Plaintiffs who otherwise would not have the economic incentive to pursue judicial redress are vested with status as equal players in the commercial marketplace. The aims of both the antitrust laws and Rule 23(b)(3) of the Federal Rules of Civil Procedure are served through class actions, yet class actions also bear the potential of negatively impacting the consuming public. This is so, because district court judges considering certification motions face seemingly contradictory standards when it comes to certifying an antitrust class. As a result, plaintiff classes are often given an …